CAREDX, INC. Depreciation and Amortization
CAREDX, INC. (CDNA) reported Depreciation and Amortization of $6.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-07-30
- CAREDX, INC. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $2.81M, a 24.48% decline year-over-year.
- CAREDX, INC. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $3.90M, a 8.31% increase year-over-year.
- CAREDX, INC. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $3.88M, a 15.50% increase year-over-year.
- CAREDX, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $3.81M, a 9.95% increase year-over-year.
- CAREDX, INC. depreciation, depletion and amortization for fiscal 2025 was $15.02M, a 5.81% increase from fiscal 2024.
- CAREDX, INC. depreciation, depletion and amortization for fiscal 2024 was $14.19M, a 1.33% decline from fiscal 2023.
- CAREDX, INC. depreciation, depletion and amortization for fiscal 2023 was $14.39M, a 24.07% increase from fiscal 2022.
- CAREDX, INC. depreciation, depletion and amortization for fiscal 2022 was $11.60M, a 31.81% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $6.71M 10-Q · filed 2026-07-30 | $10.59M derived: sum of 3 quarters · filed 2026-07-30 | $14.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $3.90M 10-Q · filed 2026-04-28 | $7.78M derived: sum of 2 quarters · filed 2026-04-28 | $11.60M derived: sum of 3 quarters · filed 2026-04-28 | $15.32M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.70M derived: sum of 2 quarters · filed 2026-02-25 | $11.42M derived: sum of 3 quarters · filed 2026-07-30 | $15.02M 10-K · filed 2026-02-25 |
| 2025-09-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.54M derived: sum of 2 quarters · filed 2026-07-30 | $11.14M 10-Q · filed 2025-11-04 | $14.50M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $7.32M 10-Q · filed 2026-07-30 | $10.68M derived: sum of 3 quarters · filed 2026-07-30 | $14.15M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $3.60M 10-Q · filed 2026-04-28 | $6.96M derived: sum of 2 quarters · filed 2026-04-28 | $10.43M derived: sum of 3 quarters · filed 2026-04-28 | $13.97M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.83M derived: sum of 2 quarters · filed 2026-02-25 | $10.37M derived: sum of 3 quarters · filed 2026-02-25 | $14.19M 10-K · filed 2026-02-25 |
| 2024-09-30 | $3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.01M derived: sum of 2 quarters · filed 2025-11-04 | $10.83M 10-Q · filed 2025-11-04 | $14.46M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $7.36M 10-Q · filed 2025-08-06 | $10.99M derived: sum of 3 quarters · filed 2026-02-25 | $14.66M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $3.82M 10-Q · filed 2025-04-30 | $7.45M derived: sum of 2 quarters · filed 2026-02-25 | $11.11M derived: sum of 3 quarters · filed 2026-02-25 | $14.78M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.29M derived: sum of 2 quarters · filed 2026-02-25 | $10.96M derived: sum of 3 quarters · filed 2026-02-25 | $14.39M 10-K · filed 2026-02-25 |
| 2023-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $7.33M derived: sum of 2 quarters · filed 2024-11-04 | $10.76M 10-Q · filed 2024-11-04 | $13.96M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $7.09M 10-Q · filed 2024-07-31 | $10.30M derived: sum of 3 quarters · filed 2025-02-28 | $13.32M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $3.43M 10-Q · filed 2024-05-09 | $6.63M derived: sum of 2 quarters · filed 2025-02-28 | $9.66M derived: sum of 3 quarters · filed 2025-02-28 | $12.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.23M derived: sum of 2 quarters · filed 2025-02-28 | $8.98M derived: sum of 3 quarters · filed 2025-02-28 | $11.60M 10-K · filed 2025-02-28 |
| 2022-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $5.77M derived: sum of 2 quarters · filed 2023-11-08 | $8.39M 10-Q · filed 2023-11-08 | $10.88M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $5.36M 10-Q · filed 2023-08-08 | $7.86M derived: sum of 3 quarters · filed 2024-02-28 | $10.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $2.62M 10-Q · filed 2023-05-10 | $5.12M derived: sum of 2 quarters · filed 2024-02-28 | $7.31M derived: sum of 3 quarters · filed 2024-02-28 | $9.47M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.70M derived: sum of 2 quarters · filed 2024-02-28 | $6.85M derived: sum of 3 quarters · filed 2024-02-28 | $8.80M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.35M derived: sum of 2 quarters · filed 2022-11-03 | $6.30M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.10M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $1.95M 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $3.43M derived: sum of 2 quarters · filed 2021-10-28 | $5.05M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $3.25M 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $1.62M 10-Q · filed 2021-05-05 | |||
| 2019-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $3.84M 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $2.38M 10-Q · filed 2020-08-04 | |||
| 2016-12-31 | $725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | $1.82M derived: sum of 2 quarters · filed 2017-04-21 | $2.66M derived: sum of 3 quarters · filed 2017-04-21 | $2.92M 10-K · filed 2017-04-21 |
| 2016-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.93M derived: sum of 2 quarters · filed 2016-11-14 | $2.19M 10-Q · filed 2016-11-14 | $2.42M derived: sum of 4 quarters · filed 2017-04-21 |
| 2016-06-30 | $836.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-22 | $1.10M 10-Q · filed 2016-08-22 | $1.32M derived: sum of 3 quarters · filed 2017-04-21 | $1.53M derived: sum of 4 quarters · filed 2017-04-21 |
| 2016-03-31 | $261.00K 10-Q · filed 2016-05-16 | $482.00K derived: sum of 2 quarters · filed 2017-04-21 | $699.00K derived: sum of 3 quarters · filed 2017-04-21 | $892.00K derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | $438.00K derived: sum of 2 quarters · filed 2017-04-21 | $631.00K derived: sum of 3 quarters · filed 2017-04-21 | $796.00K 10-K · filed 2017-04-21 |
| 2015-09-30 | $217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $410.00K derived: sum of 2 quarters · filed 2016-11-14 | $575.00K 10-Q · filed 2016-11-14 | $733.00K derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-22 | $358.00K 10-Q · filed 2016-08-22 | $516.00K derived: sum of 3 quarters · filed 2017-04-21 | $648.00K derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-03-31 | $165.00K 10-Q · filed 2016-05-16 | $323.00K derived: sum of 2 quarters · filed 2017-04-21 | $455.00K derived: sum of 3 quarters · filed 2017-04-21 | $571.00K derived: sum of 4 quarters · filed 2017-04-21 |
| 2014-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | $290.00K derived: sum of 2 quarters · filed 2017-04-21 | $406.00K derived: sum of 3 quarters · filed 2017-04-21 | $512.00K 10-K · filed 2017-04-21 |
| 2014-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $248.00K derived: sum of 2 quarters · filed 2015-11-13 | $354.00K 10-Q · filed 2015-11-13 | $477.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-28 | $222.00K 10-Q · filed 2015-08-12 | $345.00K derived: sum of 3 quarters · filed 2016-03-29 | $470.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $106.00K 10-Q · filed 2015-05-14 | $229.00K derived: sum of 2 quarters · filed 2016-03-29 | $354.00K derived: sum of 3 quarters · filed 2016-03-29 | |
| 2013-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $248.00K derived: sum of 2 quarters · filed 2016-03-29 | $663.00K 10-K · filed 2016-03-29 | |
| 2013-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $540.00K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $415.00K 10-Q · filed 2014-08-28 | |||
| 2012-12-31 | $1.07M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |